LabGenius Therapeutics
ScaleupBiotech & Life SciencesAIBritish
ML-driven antibody therapeutics company using its automated EVA platform to discover and optimise next-generation multispecific antibodies for solid tumour oncology. Rebranded to LabGenius Therapeutics following a £35 million Series B round in May 2024 led by M Ventures.
Locations
London, United Kingdom (Headquarters)
G04 Cocoa Studios, The Biscuit Factory, 100 Drummond Road, London, Greater London, SE16 4DG, United Kingdom
View on map